<?xml version="1.0" encoding="UTF-8"?>
<study api_version="0.6">
  <id>333</id>
  <name>CLL whole genome</name>
  <active>true</active>
  <user_id>145</user_id>
  <followers>
    <follower>
      <login>las</login>
      <email>las@sanger.ac.uk</email>
      <name>Lucy Stebbings</name>
      <id>21</id>
    </follower>
    <follower>
      <login>pc8</login>
      <email>pc8@sanger.ac.uk</email>
      <name>Peter Campbell</name>
      <id>51</id>
    </follower>
    <follower>
      <login>dg10</login>
      <email>dg10@sanger.ac.uk</email>
      <name>Danushka Galappaththige</name>
      <id>300</id>
    </follower>
  </followers>
  <managers>
    <manager>
      <login>sm2</login>
      <email>sm2@sanger.ac.uk</email>
      <name>Stuart McLaren</name>
      <id>145</id>
    </manager>
  </managers>
  <owners>
    <owner>
      <login>sm2</login>
      <email>sm2@sanger.ac.uk</email>
      <name>Stuart McLaren</name>
      <id>145</id>
    </owner>
  </owners>
  <!-- Family has been deprecated -->
  <family_id></family_id>
  <created_at>2009-06-24 17:43:05 +0100</created_at>
  <updated_at>2010-03-23 16:34:10 +0000</updated_at>
  <descriptors>
    <descriptor>
      <name>SNP study ID</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>What is the reason for preventing data release?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>ArrayExpress Accession Number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Please explain the reason for delaying release (e.g., pre-existing collaborative agreement)</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Alignments in BAM</name>
      <value>true</value>
    </descriptor>
    <descriptor>
      <name>Reason for delaying release</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Comment regarding prevention of data release and approval</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>How is the data release to be timed?</name>
      <value>standard</value>
    </descriptor>
    <descriptor>
      <name>Policy</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Study description</name>
      <value>Genomic libraries (500 bps) will be generated from  total genomic DNA derived from a range of cancer samples and subjected paired end sequencing on the llumina GA. Paired reads will be mapped to build 37 of the human reference genome to facilitate the generation of genome wide copy number information, and the identification of novel rearranged cancer genes and gene fusions.
</value>
    </descriptor>
    <descriptor>
      <name>EGA Policy Accession Number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Will you be using WTSI's standard access agreement?</name>
      <value>No</value>
    </descriptor>
    <descriptor>
      <name>Study name abbreviation</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Does this study contain samples that are contaminated with human DNA which must be removed prior to analysis?</name>
      <value>No</value>
    </descriptor>
    <descriptor>
      <name>Study Visibility</name>
      <value>Hold</value>
    </descriptor>
    <descriptor>
      <name>Delay for</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>SNP parent study ID</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Comment regarding data release timing and approval</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>EGA DAC Accession Number</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Has this been approved?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>Has the delay period been approved by the data sharing committee for this project?</name>
      <value></value>
    </descriptor>
    <descriptor>
      <name>What is the data release strategy for this study?</name>
      <value>managed</value>
    </descriptor>
    <descriptor>
      <name>Are all the samples to be used in this study commercially available, unlinked anonymised cell-lines?</name>
      <value>No</value>
    </descriptor>
    <descriptor>
      <name>Do any of the samples in this study contain human DNA?</name>
      <value>Yes</value>
    </descriptor>
    <descriptor>
      <name>ENA Study Accession Number</name>
      <value>EGAS00001000014</value>
    </descriptor>
    <descriptor>
      <name>Title</name>
      <value>CLL Cancer Whole Genome Sequencing</value>
    </descriptor>
    <descriptor>
      <name>Abstract</name>
      <value>The aim of this project is to identify the somatic mutations and hence the genes involved in the development of chronic lymphocytic leukemia critical through the sequencing of chronic lymphocytic leukemia cancer genomes and normal DNAs from the same individuals.  Tumour DNA will be analysed and compared to matching constitutional (normal) DNA from the same patient to identify tumour-acquired (somatic) alterations. These alterations (mutations, copy number alterations, translocations and other  genomic aberrations) will be identified in multiple tumours and then these sets will be compared against each other to determine which genes are mutated in common and which pathways have been targeted
</value>
    </descriptor>
    <descriptor>
      <name>ENA Project ID</name>
      <value>0</value>
    </descriptor>
    <descriptor>
      <name>Study Type</name>
      <value>Cancer Genomics</value>
    </descriptor>
    <descriptor>
      <name>Faculty Sponsor</name>
      <value>Peter Campbell</value>
    </descriptor>
    <descriptor>
      <name>What sort of study is this?</name>
      <value>genomic sequencing</value>
    </descriptor>
    <descriptor>
      <name>Reference Genome</name>
      <value></value>
    </descriptor>
  </descriptors>
</study>
